Dr. Helga Grupe appointed Chief Business Officer and Managing Director of Avontec GmbH

26-Sep-2007

Avontec GmbH announced that Dr. Helga Grupe was appointed Chief Business Officer and Managing Director of Avontec GmbH as of 17. September 2007.

Dr. Grupe has 16 years of experience in leadership roles in marketing and business development. She joined Avontec from Wilex AG, a publically traded German biopharmaceutical company where she served as Vice President of Business Development from 2000 to 2007. From 1996 to 2000, she held various positions with increasing responsibility in marketing and business development at Monsanto Deutschland GmbH, including Business Development Director of Europe. Prior to that, from 1995 to 1996, Dr. Grupe was Market Development Manager at Zeneca GmbH. From 1991 to 1994, she started and led the Biotechnology Co-ordination Center of the Federal State of Lower Saxony, Germany. Dr. Grupe received her PhD in biology at the University of Göttingen, Germany.

Other news from the department people

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?